MYLAN 2264 MYLAN 2264 (Terazosin 2 mg)
Pill with imprint MYLAN 2264 MYLAN 2264 is Black / Purple, Capsule-shape and has been identified as Terazosin hydrochloride 2 mg. It is supplied by Mylan Pharmaceuticals Inc..
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for MYLAN 2264 MYLAN 2264
Terazosin hydrochloride
- Imprint:
- MYLAN 2264 MYLAN 2264
- Strength:
- 2 mg
- Color:
- Black / Purple
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1
gelatin
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
ammonia
propylene glycol
dimethicone
shellac
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0937 | UDL Laboratories Inc. |
More about terazosin
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 34 Reviews – Add your own review/rating
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Other brands: Hytrin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
